Analyses revealed that while the percentage of CD4+ and CD8+ cells binding PNA, ALL, and MAL II remained constant through infection, a slight expression increase in the glycans recognized by these lectins was found at ten dpi, particularly within the CD4+ population. The gene discussed is CD8A; the disease is acute lymphoblastic leukemia.